Aurit: The main drug Dydrogesterone tablets have been added to the 2026 edition of the National Essential Medicines List.

Aoruite announced that the National Health Commission and two other departments issued a notice stating that the company's main drug, Dienogest Tablet, has been included in the "National Essential Medicine List", which will be implemented starting from September 1, 2026. Dienogest tablets can be used to treat diseases caused by insufficient endogenous progesterone. This addition to the essential medicine list will benefit the promotion of the drug, and is beneficial for the company's market expansion and long-term development, but future sales may be affected by multiple factors, leading to uncertainties.